Funded Startups in Kelowna
Disclosed round sizes in Kelowna skew toward a single outlier: Fission Uranium’s $56M round (2024-02-05) is the only disclosed amount above $50M, dwarfing…
Disclosed round sizes in Kelowna skew toward a single outlier: Fission Uranium’s $56M round (2024-02-05) is the only disclosed amount above $50M, dwarfing the next-largest disclosed figures at $7M (Minga on 2024-02-13) and $4M (Cantex Mine Development on 2025-07-11; Summit on 2024-04-04; Avant on 2023-07-17). Several entries cluster in early 2024, with 3 disclosed rounds in the Feb 5–Feb 13 window (Fission Uranium $56M on 2024-02-05; Minga $7M on 2024-02-13; Diamcor Mining $2M on 2024-01-18 sits just outside) and multiple “Series Unknown” classifications dominating across the list.
Stage and disclosure patterns are also consistent: 13 of 16 rows are labeled “Series Unknown,” while 2 rows show undisclosed amounts (CRWN.ai on 2024-11-27; Red Leaf Pulp on 2023-09-19). The 16 rows span 2021-12-16 (The Valens Company, Post-IPO Debt, $31M) through the most recent entry on 2025-07-11 (Cantex Mine Development, $4M), with recurring sectors including Natural Resources (Cantex Mine Development, Metalex Ventures, Fission Uranium, Diamcor Mining) and Biotechnology (MYND Life Sciences, Tryp Therapeutics, The Valens Company).
Most recent rounds
16 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Kelowna list, and how far above the rest is it?
Fission Uranium’s $56M (2024-02-05) is the only disclosed amount above $50M, standing well above the next-largest disclosed rounds such as Minga’s $7M (2024-02-13) and several $4M rounds (e.g., Cantex Mine Development on 2025-07-11; Summit on 2024-04-04; Avant on 2023-07-17).
Do the most recent rounds concentrate in a short date window?
Yes—there are two back-to-back recent disclosed rounds in 2025 (Cantex Mine Development $4M on 2025-07-11 and MYND Life Sciences $2M on 2025-02-11). Beyond that, early 2024 is dense: Fission Uranium ($56M on 2024-02-05) and Minga ($7M on 2024-02-13) fall within an 8-day span, with additional activity just before (Diamcor Mining $2M on 2024-01-18).
Which disclosure patterns stand out—how common are “Series Unknown” vs “undisclosed” amounts?
“Series Unknown” appears on 13 of 16 rows, including MYND Life Sciences ($2M on 2025-02-11) and Summit’s $4M (2024-04-04 is labeled Seed, but the remaining entries are mostly “Series Unknown”). Separately, 2 rows have undisclosed amounts: CRWN.ai on 2024-11-27 (undisclosed) and Red Leaf Pulp on 2023-09-19 (undisclosed).
Are any sectors over-represented in this city list?
Natural Resources is repeated across multiple rounds: Cantex Mine Development ($4M on 2025-07-11), Metalex Ventures ($740K on 2024-12-16), Fission Uranium ($56M on 2024-02-05), and Diamcor Mining ($2M on 2024-01-18). Biotechnology is also clustered with MYND Life Sciences ($2M on 2025-02-11), Tryp Therapeutics ($2M on 2023-04-12), and The Valens Company (Post-IPO Debt $31M on 2021-12-16).
What are the key outliers a researcher should check first beyond the biggest check size?
Besides the $56M Fission Uranium outlier (2024-02-05), The Valens Company’s $31M Post-IPO Debt (2021-12-16) is a structurally different financing type and far above most other disclosed amounts (for example, Vejii Holdings $140K on 2024-11-15). On disclosure, CRWN.ai (2024-11-27) and Red Leaf Pulp (2023-09-19) both show undisclosed amounts, which can indicate material rounds that aren’t comparable on size.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.